137 related articles for article (PubMed ID: 7568210)
1. Ligand-directed retroviral targeting of human breast cancer cells.
Han X; Kasahara N; Kan YW
Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9747-51. PubMed ID: 7568210
[TBL] [Abstract][Full Text] [Related]
2. Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles.
Schnierle BS; Moritz D; Jeschke M; Groner B
Gene Ther; 1996 Apr; 3(4):334-42. PubMed ID: 8732165
[TBL] [Abstract][Full Text] [Related]
3. Selective targeting and inducible destruction of human cancer cells by retroviruses with envelope proteins bearing short peptide ligands.
Gollan TJ; Green MR
J Virol; 2002 Apr; 76(7):3564-9. PubMed ID: 11884581
[TBL] [Abstract][Full Text] [Related]
4. Targeted entry via somatostatin receptors using a novel modified retrovirus glycoprotein that delivers genes at levels comparable to those of wild-type viral glycoproteins.
Li F; Ryu BY; Krueger RL; Heldt SA; Albritton LM
J Virol; 2012 Jan; 86(1):373-81. PubMed ID: 22013043
[TBL] [Abstract][Full Text] [Related]
5. Chimeric ecotropic MLV envelope proteins that carry EGF receptor-specific ligands and the Pseudomonas exotoxin A translocation domain to target gene transfer to human cancer cells.
Erlwein O; Wels W; Schnierle BS
Virology; 2002 Oct; 302(2):333-41. PubMed ID: 12441077
[TBL] [Abstract][Full Text] [Related]
6. Efficient gene delivery to quiescent interleukin-2 (IL-2)-dependent cells by murine leukemia virus-derived vectors harboring IL-2 chimeric envelope glycoproteins.
Maurice M; Mazur S; Bullough FJ; Salvetti A; Collins MK; Russell SJ; Cosset FL
Blood; 1999 Jul; 94(2):401-10. PubMed ID: 10397706
[TBL] [Abstract][Full Text] [Related]
7. Targeting retrovirus to cancer cells expressing a mutant EGF receptor by insertion of a single chain antibody variable domain in the envelope glycoprotein receptor binding lobe.
Lorimer IA; Lavictoire SJ
J Immunol Methods; 2000 Apr; 237(1-2):147-57. PubMed ID: 10725459
[TBL] [Abstract][Full Text] [Related]
8. Gamma-heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175.
Schaefer G; Fitzpatrick VD; Sliwkowski MX
Oncogene; 1997 Sep; 15(12):1385-94. PubMed ID: 9333014
[TBL] [Abstract][Full Text] [Related]
9. Retroviral vector targeting human cells via c-Kit-stem cell factor interaction.
Yajima T; Kanda T; Yoshiike K; Kitamura Y
Hum Gene Ther; 1998 Apr; 9(6):779-87. PubMed ID: 9581901
[TBL] [Abstract][Full Text] [Related]
10. Ligands for ErbB-family receptors encoded by a neuregulin-like gene.
Chang H; Riese DJ; Gilbert W; Stern DF; McMahan UJ
Nature; 1997 May; 387(6632):509-12. PubMed ID: 9168114
[TBL] [Abstract][Full Text] [Related]
11. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions.
Kasahara N; Dozy AM; Kan YW
Science; 1994 Nov; 266(5189):1373-6. PubMed ID: 7973726
[TBL] [Abstract][Full Text] [Related]
12. Antibody-mediated targeting of replication-competent retroviral vectors.
Tai CK; Logg CR; Park JM; Anderson WF; Press MF; Kasahara N
Hum Gene Ther; 2003 May; 14(8):789-802. PubMed ID: 12804141
[TBL] [Abstract][Full Text] [Related]
13. Redirecting retroviral tropism by insertion of short, nondisruptive peptide ligands into envelope.
Gollan TJ; Green MR
J Virol; 2002 Apr; 76(7):3558-63. PubMed ID: 11884580
[TBL] [Abstract][Full Text] [Related]
14. Identification of regions in the Moloney murine leukemia virus SU protein that tolerate the insertion of an integrin-binding peptide.
Wu BW; Lu J; Gallaher TK; Anderson WF; Cannon PM
Virology; 2000 Mar; 269(1):7-17. PubMed ID: 10725193
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity and specificity of directed toxins composed of diphtheria toxin and the EGF-like domain of heregulin beta1.
Landgraf R; Pegram M; Slamon DJ; Eisenberg D
Biochemistry; 1998 Mar; 37(9):3220-8. PubMed ID: 9485477
[TBL] [Abstract][Full Text] [Related]
16. Pseudotype-independent nonspecific uptake of gammaretroviral and lentiviral particles in human cells.
Voelkel C; Galla M; Dannhauser PN; Maetzig T; Sodeik B; Schambach A; Baum C
Hum Gene Ther; 2012 Mar; 23(3):274-86. PubMed ID: 22010882
[TBL] [Abstract][Full Text] [Related]
17. Improved gene transfer into human lymphocytes using retroviruses with the gibbon ape leukemia virus envelope.
Lam JS; Reeves ME; Cowherd R; Rosenberg SA; Hwu P
Hum Gene Ther; 1996 Aug; 7(12):1415-22. PubMed ID: 8844200
[TBL] [Abstract][Full Text] [Related]
18. Blocking HER-2/HER-3 function with a dominant negative form of HER-3 in cells stimulated by heregulin and in breast cancer cells with HER-2 gene amplification.
Ram TG; Schelling ME; Hosick HL
Cell Growth Differ; 2000 Mar; 11(3):173-83. PubMed ID: 10768865
[TBL] [Abstract][Full Text] [Related]
19. Herstatin inhibits heregulin-mediated breast cancer cell growth and overcomes tamoxifen resistance in breast cancer cells that overexpress HER-2.
Jhabvala-Romero F; Evans A; Guo S; Denton M; Clinton GM
Oncogene; 2003 Nov; 22(50):8178-86. PubMed ID: 14603258
[TBL] [Abstract][Full Text] [Related]
20. Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein.
Yang Y; Vanin EF; Whitt MA; Fornerod M; Zwart R; Schneiderman RD; Grosveld G; Nienhuis AW
Hum Gene Ther; 1995 Sep; 6(9):1203-13. PubMed ID: 8527479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
